Skip to main content
SIU 2026 Main banner
 
Presentation Icons
Surgery Day
Surgery Day
Bench to Bedside
Bench to Bedside
SIU@U
SIU@U

    Axel Heidenreich

    Director and Chairman
    University Hospital Cologne, Germany

    Axel Heidenreich is Professor of Urology and Chairman and Director of the Department of Urology, Uro-Oncology, Robot-Assisted and Specialized Urologic Surgery at the University Hospital in Cologne Germany since 9/2015. Before, he was the Chairman and Director of the Department of Urology of the University Hospital, RWTH Aachen, Germany from 2009 to 2015. He received his medical degree from the University of the Health Sciences in San Antonio, Texas, USA and the Johannes Gutenberg University in Mainz, Germany. He underwent his residency training program at the University Hospital in Cologne, Germany and he underwent a Clinical and Research Fellowship at the Armed Forces Institute of Pathology and the Department of Urology, Walter Reed Army Medical Centre, Washington, D.C., USA.
    Professor Heidenreich’s main interests reside in surgical and conservative uro-oncology with emphasis on prostate and testis cancer, and plastic/reconstructive surgery. He focuses very much on complex surgeries such as postchemotherapy RPLND, salvage radical prostatectomies, IVC thrombus surgery and radical cystectomies etc. He conducts basic research in the molecular pathogenesis and prognosis of urological malignancies, and has acted as principal investigator in multiple clinical trials. He has published over 600 original manuscripts in peer reviewed journals, he has edited 16 books and he contributed more than 115 book chapters.
    Professor Heidenreich is the Chairman of the Testis Cancer Guideline Panel of the EUA and hehas served as the Chairman of both the Prostate Cancer Guideline Working Group of the European Association of Urology (EAU) from 2007 to 2014, the German Testicular Cancer Study Group.
    Professor Heidenreich has received many scientific awards, including the Nietze award from the German Society of Urology, the uro-oncology award from EAU and the Paul-Mellin award from the North Rhine-Westphalia Society of Urology. Prof. Heidenreich has received many honorary memberships of International Urology Societies and International Unversities.

    Disclosure information not submitted.

    Presentation(s):